(Q55053682)

English

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

H R Prais

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

V Charlton-Menys

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Gittins

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C Roberts

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R R Davies

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Moorhouse

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Jinadev

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M France

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P G Wiles

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Dean

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P A Kalra

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J K Cruickshank

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P N Durrington

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

100-108

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Statins for improving renal outcomes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03139.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2010.03139.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21166851%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55053682&oldid=1510035370"